<DOC>
	<DOCNO>NCT02307045</DOCNO>
	<brief_summary>The integrity endothelial glucocalyx play vital role vascular permeability inflammation . Smoking cessation relate improved vascular function key component secondary cardiovascular prevention . Pharmacotherapy standard component evidence base smoke cessation treatment . This study design determine effect medically-aided smoke cessation glucocalyx thickness arterial elasticity smoke cessation program</brief_summary>
	<brief_title>Effect Smoking Reduction Endothelial Glucocalyx Vascular Function</brief_title>
	<detailed_description>The investigator examine smoker without cardiovascular disease treat transdermal nicotine patch and/or varenicline , 4 , 12 , 24 48 week treatment validate smoking cessation program . The investigator measure change baseline 4,12,24 , 48 week treatment : 1. exhale carbon monoxide ( CO , ppm ) self-reported number cigarretes/day 2. carotid-femoral pulse wave velocity ( PWVc m/sec-Complior SP ALAM ) augmentation index ( AI % -Arteriograph , TensioMed ) 3. perfused boundary region ( PBR ) sublingual arterial microvessels ( range 5-25 micrometer ) use Sideview Darkfield imaging ( Microscan , Glycocheck ) . The PBR microvessels cell-poor layer result phase separation flow red blood cell ( RBC ) plasma . The PBR include luminal part glycocalyx allow cell penetration . Increased PBR consider accurate index reduce endothelial glucocalyx thickness deeper penetration RBC glucocalyx 4. oxidative stress , thrombosis inflammatory biomarkers blood sample . Non smoker similar age sex serve control .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Smokers Coronary artery disease Heart failure Diabetes mellitus Dyslipidemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Arterial stiffness</keyword>
	<keyword>Endothelial Glycocalyx</keyword>
</DOC>